128 results on '"Hov, Johannes Roksund"'
Search Results
2. Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
3. Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits
4. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
5. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
6. Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
7. The Microbiome and Human Disease: A New Organ of Interest in Biliary Disease
8. Bowel Damage in Patients With Long-term Crohn’s Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index
9. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
10. Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
11. Impaired Immuno-Metabolic Homeostasis and Microenvironmental Influence on Neuropsychiatric Risk in Treated HIV Infection
12. Transcriptome and Proteome Analyses of Colonic Mucosa Reveal Pathomechanisms Causing Incomplete Immune Recovery in People Living with HIV
13. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC
14. Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis
15. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
16. Bowel Damage in Patients With Long-term Crohnʼs Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index
17. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
18. Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
19. Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19
20. Potential role of plasma extracellular vesicles in microbial translocation and cardiovascular risk in people living with HIV and type 2 diabetes
21. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC
22. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
23. PNPLA3 in end-stage liver disease: Alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival
24. Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.
25. Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
26. 14 The molecular basis of primary sclerosing cholangitis
27. Selective IgA deficiency in humans is associated with reduced gut microbial diversity
28. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
29. Impact of Human Immunodeficiency Virus–Related Gut Microbiota Alterations on Metabolic Comorbid Conditions
30. Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
31. Editorial: proton pump inhibition – microbial complications beyond dysbiosis
32. FRI-017-High prevalence of possible PSC recurrence post transplant evaluated by protocol biopsies
33. Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn’s Disease
34. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
35. Elevated trimethylamine‐ N ‐oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
36. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
37. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
38. Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT
39. Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease.
40. Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species.
41. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
42. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
43. Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis
44. Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseumand Candidaspecies
45. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
46. A Frequent PNPLA3 Variant Is a Sex Specific Disease Modifier in PSC Patients with Bile Duct Stenosis
47. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
48. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
49. Autoantibodies in primary sclerosing cholangitis
50. Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.